High-dose cytosine arabinoside
- 1 November 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (5) , 845-850
- https://doi.org/10.1016/0002-9343(84)90522-9
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphomaCancer Chemotherapy and Pharmacology, 1984
- High-dose cytosine arabinoside in non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1983
- Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)Cancer, 1982
- TREATMENT OF REFRACTORY ACUTE LEUKAEMIA WITH HIGH DOSE CYTOSINE ARABINOSIDEBritish Journal of Haematology, 1982
- Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemiaMedical and Pediatric Oncology, 1982
- High-dose cytosine arabinoside in the treatment of refractory acute nonlymphocytic leukemia in adults: Results of two six-day regimensMedical and Pediatric Oncology, 1982
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Drugs Five Years LaterAnnals of Internal Medicine, 1975
- Febrile Response to CytarabineJAMA, 1974